Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 and 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04201496
What this trial is testing

SGLT2 Inhibitor Adjunctive Therapy to Closed Loop Control in Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes
Ananda Basu, MD 34
Not applicableLooking for participantsNCT07297342
What this trial is testing

A Prospective Randomnised Controlled Trial Comparing Overall Patient Compliance in a Bariatric Surgical Pathway Using the Standard Versus a More Intensified and Interactive Version of the "Get Ready" Smartphone Application.

Who this might be right for
Obesity &Amp; OverweightHypertensionObstructive Sleep Apnea (OSAS)+1 more
Sint Dimpna Ziekenhuis Geel 200
Not applicableLooking for participantsNCT07457580
What this trial is testing

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

Who this might be right for
Type 1 Diabetes
Sanofi 60
Large-scale testing (Phase 3)Study completedNCT00773279
What this trial is testing

Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 242
Not applicableUnknownNCT01775059
What this trial is testing

Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4

Who this might be right for
Diabetes Mellitus Type IDiabetes Mellitus Type II
Medtronic Diabetes R&D Denmark 50
Early research (Phase 1)Ended earlyNCT05694741
What this trial is testing

Assess Safety, Tolerability, and Pharmacokinetics of AZD0186

Who this might be right for
Type 2 Diabetes
AstraZeneca 31
Not applicableStudy completedNCT00675311
What this trial is testing

Remote Monitoring in Diabetes Disease Management

Who this might be right for
Type 1 DiabetesType 2 Diabetes
LifeScan 300
Not applicableStudy completedNCT00130481
What this trial is testing

Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
University of Florida 100
Not applicableStudy completedNCT00592332
What this trial is testing

Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2

Who this might be right for
Type 1 Diabetes
Vanderbilt University 56
Large-scale testing (Phase 3)Study completedNCT05290506
What this trial is testing

Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus

Who this might be right for
PreDiabetesType 2 Diabetes
National University of Malaysia 50
Not applicableStudy completedNCT04569630
What this trial is testing

The HEADWIND Study - Part 2

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Insel Gruppe AG, University Hospital Bern 22
Not applicableEnded earlyNCT03017287
What this trial is testing

Safety and Efficacy of the GlucoMe APP in Patients With Uncontrolled Diabetes Treated With MDI

Who this might be right for
Diabetes Mellitus, Type 1 or 2
GlucoMe 40
Testing effectiveness (Phase 2)Ended earlyNCT00747006
What this trial is testing

Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Mannkind Corporation 18
Early research (Phase 1)Study completedNCT01054300
What this trial is testing

Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040)

Who this might be right for
Diabetes Mellitus, Type 2Adult
Merck Sharp & Dohme LLC 52
Early research (Phase 1)Study completedNCT01673178
What this trial is testing

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Melliuts, Type 2
Pfizer 107
Early research (Phase 1)Study completedNCT06132126
What this trial is testing

Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

Who this might be right for
HealthyType 2 Diabetes Mellitus
Eli Lilly and Company 66
Not applicableStudy completedNCT01507116
What this trial is testing

Diabetes Attitudes Wishes and Needs

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+2 more
Novo Nordisk A/S 8,985
Early research (Phase 1)Study completedNCT03973515
What this trial is testing

Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type2 Diabetes Mellitus
PegBio Co., Ltd. 16
Not applicableStudy completedNCT03416855
What this trial is testing

A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 768
Early research (Phase 1)Study completedNCT02073227
What this trial is testing

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components

Who this might be right for
Healthy Volunteers
Janssen Research & Development, LLC 52
Next Page